Related references
Note: Only part of the references are listed.The nitrosamine contamination of drugs, part 3: Quantification of 4-Methyl-1-nitrosopiperazine in rifampicin capsules by LC-MS/HRMS
Jonas Wohlfart et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2021)
Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA)
Joel P. Bercu et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2021)
Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug-Drug Interaction Studies
Mohamed Elmeliegy et al.
CLINICAL PHARMACOKINETICS (2020)
Are all nitrosamines concerning? A review of mutagenicity and carcinogenicity data
Andrew Thresher et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Critical review of major sources of human exposure to N-nitrosamines
Adam J. Gushgari et al.
CHEMOSPHERE (2018)
Prediction of Drug-Drug Interactions Arising from CYP3A induction Using a Physiologically Based Dynamic Model
Lisa M. Almond et al.
DRUG METABOLISM AND DISPOSITION (2016)
Dietary exposure to volatile and non-volatile N-nitrosamines from processed meat products in Denmark
S. S. Herrmann et al.
FOOD AND CHEMICAL TOXICOLOGY (2015)
Pharmacokinetics of Lopinavir in HIV-Infected Adults Receiving Rifampin with Adjusted Doses of Lopinavir-Ritonavir Tablets
Eric H. Decloedt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers
Jonathan Bullman et al.
EPILEPSIA (2011)
Gefitinib-phenytoin interaction is not correlated with the 14C-erythromycin breath test in healthy male volunteers
Stephanie Chhun et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastoma
Stuart A. Grossman et al.
NEURO-ONCOLOGY (2008)
Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites
JT Backman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol
HC Swaisland et al.
CLINICAL PHARMACOKINETICS (2005)
Coadministration of Lopinavir/Ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction
ML Lim et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Evaluation of potential losartan-phenytoin drug interactions in healthy volunteers
TL Fischer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine
YWJ Wong et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials
WJ Burman et al.
CLINICAL PHARMACOKINETICS (2001)
Share Paper
